Comprehensive analysis of eosinophils and type 2 innate lymphoid cells in patients with severe asthma before and after mepolizumab treatment - Comprehensive analysis of eosinophils and type 2 innate lymphoid cells in patients with severe asthma before and after mepolizumab treatment (MEISEA)

Keio University0 个研究点目标入组 40 人开始时间: 2023年11月24日最近更新: 2024年1月22日

适应症

试验速览

暂无简介。

•Patients are not eligible for this study if they met any of the following criteria Has previously been treated with mepolizumab before the study Has a history of acute viral infection up to 4 weeks prior to blood sampling Has been treated with systemic corticosteroids including methylprednisolone up to 4 weeks prior to blood sampling History of widespread lung disease Has cancer/malignancy under treatment During the period of pregnancy Individuals whom the principal investigators judge as inappropriate registers Healthy volunteers are not eligible for this study if they met any of the following criteria: Has a history of acute viral infection up to 4 weeks prior to blood sampling Individuals whom the principal investigators judge as inappropriate registers

发起方